Grand Pharmaceutical Group (HKSE:00512) Change In Inventory : HK$0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Grand Pharmaceutical Group Change In Inventory?

Grand Pharmaceutical Group's change in inventory for the quarter that ended in Dec. 2023 was HK$0 Mil. It means Grand Pharmaceutical Group's inventory stayed the same from Jun. 2023 to Dec. 2023 .

Grand Pharmaceutical Group's change in inventory for the fiscal year that ended in Dec. 2023 was HK$-99 Mil. It means Grand Pharmaceutical Group's inventory increased by HK$99 Mil from Dec. 2022 to Dec. 2023 .

Grand Pharmaceutical Group's Total Inventories for the quarter that ended in Dec. 2023 was HK$1,389 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Grand Pharmaceutical Group's Days Inventory for the quarter that ended in Dec. 2023 was 120.87.

Inventory Turnover measures how fast the company turns over its inventory within a year. Grand Pharmaceutical Group's Inventory Turnover for the quarter that ended in Dec. 2023 was 1.51.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Grand Pharmaceutical Group's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.27.

Grand Pharmaceutical Group Change In Inventory Historical Data

The historical data trend for Grand Pharmaceutical Group's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grand Pharmaceutical Group Change In Inventory Chart

Grand Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-65.12

-100.96

-118.74

-295.28

-99.41

Grand Pharmaceutical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Grand Pharmaceutical Group Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

Grand Pharmaceutical Group (HKSE:00512) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Grand Pharmaceutical Group's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	1248.1055	/	1884.475	*	365 / 2
	=	120.87

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Grand Pharmaceutical Group's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1884.475	/	1248.1055
	=	1.51

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Grand Pharmaceutical Group's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1248.1055	/	4540.104
	=	0.27

Grand Pharmaceutical Group Change In Inventory Related Terms

Thank you for viewing the detailed overview of Grand Pharmaceutical Group's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Grand Pharmaceutical Group (HKSE:00512) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grand Pharmaceutical Group Ltd (HKSE:00512) » Definitions » Change In Inventory

Traded in Other Exchanges

MX6A:Germany

Address

99 Queen's Road, Units 3302, 33rd Floor, The Center, Central, Hong Kong, HKG

Website

http://www.chinagrandpharm.com

Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a drug manufacturer. The company through its subsidiaries manufactures and sells pharmaceutical preparations and medical devices, biotechnology products, nutrition products, specialized pharmaceutical raw materials, and other products. Geographically, it derives a majority of revenue from China and also has a presence in America; Europe; Asia other than the PRC and others.

Executives

Shang Hai Yuan Da Chan Rong Tou Zi Guan Li You Xian Gong Si	2101 Beneficial owner
Hu Kaijun	2201 Interest of corporation controlled by you
East Ocean Capital (hong Kong) Company Limited	2101 Beneficial owner
Lion River I N.v.	2201 Interest of corporation controlled by you
Li Zhenfu	2201 Interest of corporation controlled by you
Gl Partners Capital Management Ltd.	2201 Interest of corporation controlled by you
Assicurazioni Generali Spa	2201 Interest of corporation controlled by you
Citic Group Corporation	2201 Interest of corporation controlled by you
Citic Limited	2201 Interest of corporation controlled by you
China Citic Bank Corporation Limited	2201 Interest of corporation controlled by you
Cncb (hong Kong) Investment Limited	2106 Person having a security interest in shares
Grand (hongkong) International Investments Holdings Limited
Chau Tung
Zhong Guo Yuan Da Ji Tuan You Xian Ze Ren Gong Si
Outwit Investments Limited

Grand Pharmaceutical Group (HKSE:00512) Headlines

No Headlines